A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats

American Journal of Pathology

Volumn 179, Issue 4, 2011, Pages 2042-2052

  Choi, In Young ^a   Lee, Jae Chul ^b   Ju, Chung ^a   Hwang, Sunyoung ^a   Cho, Geum Sil ^a   Lee, Hyuk Woo ^c   Choi, Won Jun ^d   Jeong, Lak Shin ^c   Kim, Won Ki ^a  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Ewha Womans University   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N6 (3 IODOBENZYL) 5 N METHYLCARBAMOYL 4 THIOADENOSINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE A3 RECEPTOR AGONIST; CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LJ 529; MONOCYTE CHEMOTACTIC PROTEIN 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BRAIN ARTERY; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CORPUS CALLOSUM; EXCITOTOXICITY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFLAMMATION; INFLAMMATORY CELL; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; RECEPTOR DOWN REGULATION;

ADENOSINE; ADENOSINE A3 RECEPTOR AGONISTS; ANIMALS; BRAIN INFARCTION; BRAIN INJURIES; BRAIN ISCHEMIA; CELL MOVEMENT; CHEMOKINE CCL2; GLUCOSE; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICROGLIA; MONOCYTES; N-METHYLASPARTATE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RHO GTP-BINDING PROTEINS; THIONUCLEOSIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053271201     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.006     Document Type: Article

References (66)

1. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 22 1999 391 397 (Pubitemid 29453643)
2. I. Margaill, S. Parmentier, J. Callebert, M. Allix, R.G. Boulu, and M. Plotkine Short therapeutic window for MK-801 in transient focal cerebral ischemia in normotensive rats J Cereb Blood Flow Metab 16 1996 107 113 (Pubitemid 26042688)
3. R.H. Hatfield, R. Gill, and C. Brazell The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model Eur J Pharmacol 216 1992 1 7
4. J. Valtysson, L. Hillered, P. Andiné, H. Hagberg, and L. Persson Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation Acta Neurochir (Wien) 129 1994 58 63 (Pubitemid 24225621)
5. D.K. Von Lubitz, R.J. McKenzie, R.C. Lin, T.M. Devlin, and P. Skolnick MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia Eur J Pharmacol 233 1993 95 100 (Pubitemid 23091748)
6. F. Colbourne, H. Li, A.M. Buchan, and J.A. Clemens Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats Stroke 30 1999 662 668 (Pubitemid 29115408)
7. C.J. Price, E.A. Warburton, and D.K. Menon Human cellular inflammation in the pathology of acute cerebral ischaemia J Neurol Neurosurg Psychiatry 74 2003 1476 1484
8. A.K. Dixon, A.K. Gubitz, D.J. Sirinathsinghji, P.J. Richardson, and T.C. Freeman Tissue distribution of adenosine receptor mRNAs in the rat Br J Pharmacol 118 1996 1461 1468 (Pubitemid 26248800)
9. M.R. Atkinson, A. Townsend-Nicholson, J.K. Nicholl, G.R. Sutherland, and P.R. Schofield Cloning, characterisation and chromosomal assignment of the human adenosine A3 receptor (ADORA3) gene Neurosci Res 29 1997 73 79 (Pubitemid 27365679)
10. S. Bar-Yehuda, M.H. Silverman, W.D. Kerns, A. Ochaion, S. Cohen, and P. Fishman The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis Expert Opin Investig Drugs 16 2007 1601 1613 (Pubitemid 350028410)
11. A. Ochaion, S. Bar-Yehuda, S. Cohen, F. Barer, R. Patoka, H. Amital, T. Reitblat, A. Reitblat, J. Ophir, I. Konfino, Y. Chowers, S. Ben-Horin, and P. Fishman The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease Cell Immunol 258 2009 115 122
12. G. Haskó, Z.H. Németh, E.S. Vizi, A.L. Salzman, and C. Szabó An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice Eur J Pharmacol 358 1998 261 268 (Pubitemid 28498186)
13. R. Wagner, K.C. Ngamsri, S. Stark, I. Vollmer, and J. Reutershan Adenosine receptor A3 is a critical mediator in LPS-induced pulmonary inflammation Am J Physiol Lung Cell Mol Physiol 299 2010 L502 L512
14. Z.D. Ge, D. van der Hoeven, J.E. Maas, T.C. Wan, and J.A. Auchampach A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells J Mol Cell Cardiol 49 2010 280 286
15. G.J. Chen, B.K. Harvey, H. Shen, J. Chou, A. Victor, and Y. Wang Activation of adenosine A3 receptors reduces ischemic brain injury in rodents J Neurosci Res 84 2006 1848 1855 (Pubitemid 44892618)
16. I.M. Fedorova, M.A. Jacobson, A. Basile, and K.A. Jacobson Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration Cell Mol Neurobiol 23 2003 431 447 (Pubitemid 36676284)
17. D.K. Von Lubitz, R.C. Lin, P. Popik, M.F. Carter, and K.A. Jacobson Adenosine A3 receptor stimulation and cerebral ischemia Eur J Pharmacol 263 1994 59 67
18. D.K. Von Lubitz, K.L. Simpson, and R.C. Lin Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke Ann N Y Acad Sci 939 2001 85 96 (Pubitemid 32621718)
19. H.O. Kim, X.D. Ji, S.M. Siddiqi, M.E. Olah, G.L. Stiles, and K.A. Jacobson 2-Substitution of N6-benzyladenosine-5′-uronamides enhances selectivity for A3 adenosine receptors J Med Chem 37 1994 3614 3621 (Pubitemid 24334616)
20. S. Tchilibon, B.V. Joshi, S.K. Kim, H.T. Duong, Z.G. Gao, and K.A. Jacobson (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists J Med Chem 48 2005 1745 1758 (Pubitemid 40396308)
21. L.S. Jeong, D.Z. Jin, H.O. Kim, D.H. Shin, H.R. Moon, P. Gunaga, M.W. Chun, Y.C. Kim, N. Melman, Z.G. Gao, and K.A. Jacobson N6-substituted D-4′-thioadenosine-5′-methyluronamides: potent and selective agonists at the human A3 adenosine receptor J Med Chem 46 2003 3775 3777 (Pubitemid 37034129)
22. L. Belayev, O.F. Alonso, R. Busto, W. Zhao, and M.D. Ginsberg Middle cerebral artery occlusion in the rat by intraluminal suture Neurological and pathological evaluation of an improved model Stroke 27 1996 1616 1622 discussion 1623
23. A.H. Li, S. Moro, N. Melman, X.D. Ji, and K.A. Jacobson Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4- dialkylpyridine derivatives as selective A3 adenosine receptor antagonists J Med Chem 41 1998 3186 3201 (Pubitemid 28376524)
24. C. Zocchi, E. Ongini, A. Conti, A. Monopoli, A. Negretti, P.G. Baraldi, and S. Dionisotti The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist J Pharmacol Exp Ther 276 1996 398 404 (Pubitemid 126660473)
25. Z.D. Ge, J.N. Peart, L.M. Kreckler, T.C. Wan, M.A. Jacobson, G.J. Gross, and J.A. Auchampach Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5′-N- methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor J Pharmacol Exp Ther 319 2006 1200 1210
26. A. Melani, L. Pantoni, F. Bordoni, M. Gianfriddo, L. Bianchi, M.G. Vannucchi, R. Bertorelli, A. Monopoli, and F. Pedata The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat Brain Res 959 2003 243 250 (Pubitemid 35472186)
27. P. Popoli, R. Reggio, and A. Pezzola Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine- lesioned rats Lack of tolerance after chronic caffeine intake Neuropsychopharmacology 22 2000 522 529 (Pubitemid 30145620)
28. Y. Yang, A. Shuaib, and Q. Li Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method J Neurosci Methods 84 1998 9 16 (Pubitemid 28485041)
29. R.A. Swanson, M.T. Morton, G. Tsao-Wu, R.A. Savalos, C. Davidson, and F.R. Sharp A semiautomated method for measuring brain infarct volume J Cereb Blood Flow Metab 10 1990 290 293 (Pubitemid 20096202)
30. C. Ju, Y.J. Oh, B.H. Han, H.S. Kim, H.C. Kim, and W.K. Kim Intracellular pH-dependent peroxynitrite-evoked synergistic death of glucose-deprived astrocytes Free Radic Biol Med 37 2004 1160 1169 (Pubitemid 39296741)
31. A.S. Waggoner Dye indicators of membrane potential Annu Rev Biophys Bioeng 8 1979 47 68
32. H.H. Schmidt, T.D. Warner, M. Nakane, U. Förstermann, and F. Murad Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages [Erratum appeared in Mol Pharmacol 1992, 42:174] Mol Pharmacol 41 1992 615 624 (Pubitemid 23021446)
33. J.F. Chen, and F. Pedata Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors Curr Pharm Des 14 2008 1490 1499 (Pubitemid 351997814)
34. J.C. Lee, G.S. Cho, H.J. Kim, J.H. Lim, Y.K. Oh, W. Nam, J.H. Chung, and W.K. Kim Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum Glia 50 2005 168 181 (Pubitemid 40695270)
35. F.G. Sajjadi, K. Takabayashi, A.C. Foster, R.C. Domingo, and G.S. Firestein Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors J Immunol 156 1996 3435 3442 (Pubitemid 26124449)
36. J.Y. Lee, B.S. Jhun, Y.T. Oh, J.H. Lee, W. Choe, H.H. Baik, J. Ha, K.S. Yoon, S.S. Kim, and I. Kang Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells Neurosci Lett 396 2006 1 6 (Pubitemid 43233777)
37. G. Haskó, C. Szabó, Z.H. Németh, V. Kvetan, S.M. Pastores, and E.S. Vizi Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 2647 macrophages and in endotoxemic mice J Immunol 157 1996 4634 4640 (Pubitemid 126449386)
38. T.L. Bowlin, D.R. Borcherding, C.K. Edwards 3rd, and C.D. McWhinney Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo Cell Mol Biol (Noisy-le-grand) 43 1997 345 349
39. A. Hall Rho GTPases and the actin cytoskeleton Science 279 1998 509 514 (Pubitemid 28067271)
40. G.E. Jones Cellular signaling in macrophage migration and chemotaxis J Leukoc Biol 68 2000 593 602
41. F. Sánchez-Madrid, and M.A. del Pozo Leukocyte polarization in cell migration and immune interactions EMBO J 18 1999 501 511 (Pubitemid 29057235)
42. J.J. Hendriks, J. Alblas, S.M. van der Pol, E.A. van Tol, C.D. Dijkstra, and H.E. de Vries Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis J Exp Med 200 2004 1667 1672 (Pubitemid 40094190)
43. H. Honing, T.K. van den Berg, S.M. van der Pol, C.D. Dijkstra, R.A. van der Kammen, J.G. Collard, and H.E. de Vries RhoA activation promotes transendothelial migration of monocytes via ROCK J Leukoc Biol 75 2004 523 528 (Pubitemid 38316384)
44. E.E. Tyrala, X. Chen, and G. Boden Glucose metabolism in the infant weighing less than 1100 grams J Pediatr 125 1994 283 287 (Pubitemid 24253016)
45. J. Jordan, T. Segura, D. Brea, M.F. Galindo, and J. Castillo Inflammation as therapeutic objective in stroke Curr Pharm Des 14 2008 3549 3564
46. D. van der Hoeven, T.C. Wan, and J.A. Auchampach Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils Mol Pharmacol 74 2008 685 696
47. D. Amantea, G. Nappi, G. Bernardi, G. Bagetta, and M.T. Corasaniti Post-ischemic brain damage: pathophysiology and role of inflammatory mediators FEBS J 276 2009 13 26
48. R. Brouns, and P.P. De Deyn The complexity of neurobiological processes in acute ischemic stroke Clin Neurol Neurosurg 111 2009 483 495
49. L. Martin, S.C. Pingle, D.M. Hallam, L.P. Rybak, and V. Ramkumar Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2 J Pharmacol Exp Ther 316 2006 71 78 (Pubitemid 41832582)
50. C. Szabó, G.S. Scott, L. Virág, G. Egnaczyk, A.L. Salzman, T.P. Shanley, and G. Haskó Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists Br J Pharmacol 125 1998 379 387 (Pubitemid 28425204)
51. C.A. Salvatore, S.L. Tilley, A.M. Latour, D.S. Fletcher, B.H. Koller, and M.A. Jacobson Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells J Biol Chem 275 2000 4429 4434 (Pubitemid 30094686)
52. K.A. Jacobson Adenosine A3 receptors: novel ligands and paradoxical effects Trends Pharmacol Sci 19 1998 184 191 (Pubitemid 28255405)
53. B.P. Ramakers, N.P. Riksen, G.A. Rongen, J.G. van der Hoeven, P. Smits, and P. Pickkers The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation Cytokine 35 2006 95 99 (Pubitemid 44485538)
54. C. van der Putten, E.A. Zuiderwijk-Sick, L. van Straalen, E.D. de Geus, L.A. Boven, I. Kondova, A.P. IJzerman, and J.J. Bajramovic Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia J Immunol 182 2009 7603 7612
55. B.A. Walker, M.A. Jacobson, D.A. Knight, C.A. Salvatore, T. Weir, D. Zhou, and T.R. Bai Adenosine A3 receptor expression and function in eosinophils Am J Respir Cell Mol Biol 16 1997 531 537 (Pubitemid 127498285)
56. C.E. Walters, G. Pryce, D.J. Hankey, S.M. Sebti, A.D. Hamilton, D. Baker, J. Greenwood, and P. Adamson Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis J Immunol 168 2002 4087 4094 (Pubitemid 34298416)
57. W.E. Allen, G.E. Jones, J.W. Pollard, and A.J. Ridley Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages J Cell Sci 110 1997 707 720 (Pubitemid 27156320)
58. R.A. Worthylake, S. Lemoine, J.M. Watson, and K. Burridge RhoA is required for monocyte tail retraction during transendothelial migration J Cell Biol 154 2001 147 160 (Pubitemid 34289285)
59. J. Xu, F. Wang, A. Van Keymeulen, P. Herzmark, A. Straight, K. Kelly, Y. Takuwa, N. Sugimoto, T. Mitchison, and H.R. Bourne Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils Cell 114 2003 201 214 (Pubitemid 36936914)
60. M.P. Abbracchio, G. Rainaldi, A.M. Giammarioli, S. Ceruti, R. Brambilla, F. Cattabeni, D. Barbieri, C. Franceschi, K.A. Jacobson, and W. Malorni The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: studies in human astroglioma cells Biochem Biophys Res Commun 241 1997 297 304 (Pubitemid 28020096)
61. E.M. Abd-El-Basset, J. Prashanth, and K.V. Ananth Lakshmi Up-regulation of cytoskeletal proteins in activated microglia Med Princ Pract 13 2004 325 333 (Pubitemid 39370431)
62. A.M. Pugliese, E. Coppi, R. Volpini, G. Cristalli, R. Corradetti, L.S. Jeong, K.A. Jacobson, and F. Pedata Role of adenosine A3 receptors on CA1 hippocampal neurotransmission during oxygen-glucose deprivation episodes of different duration Biochem Pharmacol 74 2007 768 779 (Pubitemid 47087760)
63. H. Hagberg, P. Andersson, J. Lacarewicz, I. Jacobson, S. Butcher, and M. Sandberg Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia J Neurochem 49 1987 227 231 (Pubitemid 17108253)
64. S. Latini, F. Bordoni, R. Corradetti, G. Pepeu, and F. Pedata Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions Brain Res 794 1998 325 328 (Pubitemid 28300467)
65. E.C. Klaasse, A.P. Ijzerman, W.J. de Grip, and M.W. Beukers Internalization and desensitization of adenosine receptors Purinergic Signal 4 2008 21 37
66. Y.C. Weng, and J. Kriz Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia Exp Neurol 204 2007 433 442 (Pubitemid 46330289)